Alliance for Clinical Trials in Oncology
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 5
- Registration Number
- NCT00004893
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
๐บ๐ธVeterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
๐บ๐ธVeterans Affairs Medical Center - Syracuse, Syracuse, New York, United States
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 40
- Registration Number
- NCT00003276
- Locations
- ๐บ๐ธ
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
๐บ๐ธCCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
๐บ๐ธCCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
- First Posted Date
- 2004-04-29
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 27
- Registration Number
- NCT00006483
- Locations
- ๐บ๐ธ
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
๐บ๐ธCCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
๐บ๐ธCCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
- First Posted Date
- 2004-04-28
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 5
- Registration Number
- NCT00004933
- Locations
- ๐บ๐ธ
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
๐บ๐ธVeterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
๐บ๐ธCCOP - Central Illinois, Decatur, Illinois, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
- Conditions
- Interventions
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 29
- Registration Number
- NCT00003621
- Locations
- ๐บ๐ธ
CentraCare Clinic, Saint Cloud, Minnesota, United States
๐บ๐ธAltru Health Systems, Grand Forks, North Dakota, United States
๐บ๐ธCCOP - Ochsner, New Orleans, Louisiana, United States
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
- Conditions
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 180
- Registration Number
- NCT00002889
- Locations
- ๐บ๐ธ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
๐บ๐ธDuke Comprehensive Cancer Center, Durham, North Carolina, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
- Conditions
- Interventions
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 51
- Registration Number
- NCT00002768
- Locations
- ๐บ๐ธ
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
๐บ๐ธMarlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
๐บ๐ธSt. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 29
- Registration Number
- NCT00002501
- Locations
- ๐บ๐ธ
State University of New York - Upstate Medical University, Syracuse, New York, United States
๐บ๐ธMarlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
๐บ๐ธEllis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- First Posted Date
- 2004-04-20
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 54
- Registration Number
- NCT00005828
- Locations
- ๐บ๐ธ
CCOP - Carle Cancer Center, Urbana, Illinois, United States
๐บ๐ธCCOP - Duluth, Duluth, Minnesota, United States
๐บ๐ธMedcenter One Health System, Bismarck, North Dakota, United States
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Interventions
- First Posted Date
- 2004-04-19
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 40
- Registration Number
- NCT00005810
- Locations
- ๐บ๐ธ
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
๐บ๐ธUCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States